Long-acting injectable HIV therapies: the next frontier: Republication

J Thornhill, C Orkin - Current Opinion in HIV and AIDS, 2021 - journals.lww.com
However, despite evidence that suggests that these therapies are efficacious and
acceptable to patients, the challenge of integrating these agents into our current healthcare …

Dopamine receptor partial agonists for the treatment of bipolar disorder

JM Azorin, N Simon - Drugs, 2019 - Springer
Bipolar disorder is a chronic, disabling, and costly illness with frequent relapses and
recurrences, high rates of co-morbid conditions, and poor adherence to treatment. Mood …

[HTML][HTML] Atypical injectable antipsychotics for schizophrenia or bipolar disorder: a review of clinical effectiveness and cost-effectiveness

T Narain, C Ford - 2019 - europepmc.org
Atypical injectable antipsychotics are second-generation therapeutics that can be used as
an alternative to first-generation antipsychotics to treat patients with schizophrenia or bipolar …

Budget impact analysis of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA

M Augusto, M Greene, M Touya… - Journal of …, 2018 - becarispublishing.com
Aim: To estimate the budget impact (BI) of introducing aripiprazole once-monthly 400
mg/300 mg (AOM 400) in the maintenance monotherapy treatment of bipolar I disorder …

Pharmacoeconomics

R Dodel, C Kruse, A Conrads-Frank… - …, 2020 - Springer
Newly developed drugs and medical devices have made a major contribution to improving
the health of populations. However, the rise in health care expenditure has been a major …

[PDF][PDF] Presentada a la Honorable Junta Directiva de la Facultad de Ciencias Médicas de la Universidad de San Carlos de Guatemala

MDECAS SIGNOS, PORD DE DESHIDRATACIÓN - 2016 - biblioteca.medicina.usac.edu.gt
RESUMEN OBJETIVO: Analizar el grado de información, actitudes y prácticas en madres de
niños menores de 5 años sobre signos de deshidratación por diarrea antes y después de …

[引用][C] CADTH Health Technology Review Cost-Effectiveness of Second-Generation Injectable Antipsychotic Drugs

N Darvesh, D MacDougall, Q Mahood